NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 1 நாளுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
MPS Ltd H1 FY27 Revenue Up 17.8% to ₹448.5 Cr; Raises FY27 EBITDA Floor to ₹310 Cr
MPS Limited published its Q2 & H1 FY27 earnings call transcript, highlighting that H1 FY27 was its most profitable half-year, with revenue rising 17.8% YoY to ₹448.5 crore and EBITDA up 39% to ₹154 crore at a 34.3% margin. Management upgraded its full-year FY27 EBITDA floor guidance to at least ₹310 crore, up from an earlier expectation of crossing ₹300 crore. The company reported zero debt after repaying borrowing for Unbound Medicine and held ₹163 crore in cash as of September 30, 2026. Top five client concentration decreased to 46% of revenue from 51% a year ago, reflecting client diversification.
உச்சம் நம்பிக்கை
என்ன மாறியதுRelease of the verbatim transcript for the Q2 & H1 FY27 earnings call held on November 04, 2026.
ஏன் இது முக்கியம்Provides operational details on margin expansion, debt elimination, cross-selling across acquired platforms (AJE, Unbound), and an upward revision of FY27 EBITDA guidance.
📅 குறுகிய காலம்Earnings transcript reinforces strong operating leverage and solid debt-free balance sheet, supporting market sentiment following Q2 results.
📈 நீண்ட காலம்Demonstrates structural margin expansion driven by platform/AI integration and recurring content revenues, supporting the long-term target toward ₹1,500 crore revenue.
⚠ அபாய எச்சரிக்கைகள்
Client concentration remains moderately high, with top 5 clients contributing 46% of revenue
Potential integration and capital allocation risks from future M&A deals
👀 கவனிக்க வேண்டியவை
Track execution in H2 FY27 against the raised ₹310+ crore EBITDA guidance, particularly Q4 billing of new research mandates and progress in Unbound Medicine's expansion into hospital systems.
MPS Ltd Q2 FY27: EBITDA up 27.4% YoY to ₹77 Cr; Guides ₹300+ Cr EBITDA for FY27
MPS Limited reported a 15.35% YoY increase in consolidated revenue to ₹224.29 Cr for Q2 FY27, with EBITDA climbing 27.39% YoY to ₹77.03 Cr. The company achieved an all-time high EBITDA margin of 34.34%, driven by AI-enabled production and operating leverage in Research Solutions (margin at 48.17%). H1 FY27 EBITDA reached ₹154 Cr, tracking ahead of its full-year guidance of ₹300+ Cr. MPS repaid all borrowings related to the Unbound Medicine acquisition in August 2026, ending the quarter with zero debt and cash of ₹163.23 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுMPS published its Q2 & H1 FY27 investor presentation, confirming record EBITDA margins, debt-free balance sheet status, and visibility on achieving >₹300 Cr EBITDA in FY27.
ஏன் இது முக்கியம்Demonstrates operating leverage and margin expansion from AI tools in Research Solutions, while fully integrating Unbound Medicine and deleveraging ahead of future M&A.
📅 குறுகிய காலம்Sentiment is supported by record 34.34% quarterly operating margins and comfortable delivery against the ₹300+ Cr annual EBITDA target.
📈 நீண்ட காலம்AI deployment in core Research delivery and a debt-free balance sheet position MPS well to execute its stated strategy of scaling revenue to ₹1,500 Cr by FY27/28.
⚠ அபாய எச்சரிக்கைகள்
Integration risks from the active M&A pipeline
Customer concentration with top 5 clients contributing 46% of revenue in H1 FY27
👀 கவனிக்க வேண்டியவை
Monitor the onboarding of 25 new journals and the new research integrity mandate billing in H2 FY27, alongside execution on US state education adoptions.
MPS Ltd Q2 FY27 Consolidated Revenue Up 15.3% YoY to ₹224.29 Cr; PAT at ₹52.10 Cr
MPS Limited reported consolidated revenue from operations of ₹224.29 Cr for Q2 FY27, up 15.3% YoY compared to ₹194.44 Cr in Q2 FY26 and flat QoQ (₹224.24 Cr). Consolidated net profit for the quarter stood at ₹52.10 Cr, down 6.0% YoY from ₹55.45 Cr in Q2 FY26 (which included an exceptional gain of ₹12.81 Cr), but up 3.4% QoQ from ₹50.39 Cr. For H1 FY27, revenue reached ₹448.53 Cr (vs ₹380.72 Cr in H1 FY26) with PAT at ₹102.49 Cr (vs ₹90.68 Cr in H1 FY26). The board also approved the re-appointment of Independent Director Ms. Divya Verma for a second 5-year term subject to shareholder approval.
உச்சம் நம்பிக்கை
என்ன மாறியதுReported Q2 and H1 FY27 financial results and approved board re-appointment of an Independent Director along with amendments to the PIT Code.
ஏன் இது முக்கியம்Demonstrates steady revenue execution (~15% YoY growth in H1) supporting the company's long-term target of scaling towards ₹1,500 Cr revenue, though base-effect exceptional items tempered YoY PAT growth.
Revenue from operations (Q2 FY27): 22,429 lacsNet Profit (Q2 FY27): 5,210 lacsTotal Income (Q2 FY27): 22,653 lacsH1 FY27 Revenue from operations: 44,853 lacsH1 FY27 Net Profit: 10,249 lacs
📅 குறுகிய காலம்Likely neutral reaction as top-line growth is stable but flat sequentially, with underlying PBT showing solid operational gains after normalizing for base-period exceptional items.
📈 நீண்ட காலம்H1 annualizes to ~₹900 Cr in revenue, tracking ahead of FY26 levels (₹768 Cr) and supporting the trajectory toward long-term scaling targets.
⚠ அபாய எச்சரிக்கைகள்
Sequential top-line growth was flat (₹224.29 Cr vs ₹224.24 Cr in Q1 FY27)
Execution and integration risks from future aggressive acquisition strategy
👀 கவனிக்க வேண்டியவை
Track operational commentary in the upcoming earnings call regarding organic growth momentum across Research and Education Solutions, and watch for progress on the company's planned M&A pipeline.
MPS Ltd Unsecured Creditors Approve Merger with ADI BPO Services by 100% Majority
Unsecured creditors of MPS Limited have unanimously approved the Scheme of Amalgamation with ADI BPO Services Limited at an NCLT-convened meeting held on August 22, 2026. A total of 13 unsecured creditors representing ₹71,06,680 in value voted 100% in favour of the resolution, with zero votes against or invalid. The merger represents a key procedural milestone under Sections 230-232 of the Companies Act, 2013, towards integrating ADI BPO Services into MPS Limited.
உச்சம் நம்பிக்கை
என்ன மாறியதுUnsecured creditors of MPS Limited have formally approved the amalgamation scheme with ADI BPO Services Limited via NCLT-directed voting.
ஏன் இது முக்கியம்Securing creditor clearance removes a key statutory hurdle in the merger process, aiding operational integration and corporate restructuring.
Total creditor value voted in favour: ₹71,06,680Creditors voting in favour: 13Total unsecured creditors as on cut-off: 39Approval percentage: 100%
📅 குறுகிய காலம்Clearance from creditors moves the merger to the next phase of regulatory and NCLT approval without contentious objections.
📈 நீண்ட காலம்Consolidation of ADI BPO Services into MPS Limited should simplify corporate structure and streamline operational synergies.
⚠ அபாய எச்சரிக்கைகள்
Final sanction from the National Company Law Tribunal (NCLT) is still pending
👀 கவனிக்க வேண்டியவை
Track subsequent regulatory filings regarding final NCLT Chennai approval hearings and the effective date of the amalgamation.
MPS Ltd Issues Addendum for ADI BPO Merger; Shareholder Meeting Set for Aug 22, 2026
MPS Limited has issued an addendum to its July 22, 2026, notice regarding the merger of ADI BPO Services Limited into the company. This update, prompted by BSE observations, includes an abridged prospectus for the transferor company and confirms that public shareholding will remain unchanged post-merger. A meeting for equity shareholders and unsecured creditors is scheduled for August 22, 2026, to seek approval for the scheme. The merger is a component of MPS's stated goal to reach ₹1,500 Cr in revenue by FY27/28.
உச்சம் நம்பிக்கை
என்ன மாறியதுMPS Limited added specific regulatory disclosures, including an abridged prospectus and tax dispute details for ADI BPO, to its existing merger notice following stock exchange feedback.
ஏன் இது முக்கியம்This is a necessary procedural step to complete the amalgamation of ADI BPO, which supports the company's aggressive M&A-led growth strategy to double its revenue by FY28.
Meeting Date: 22 ஆகஸ்ட் 2026ADI BPO Disputed Tax Demands: ₹40.58 கோடிTax Dispute vs MPS TTM Revenue: 5.28%MPS TTM Revenue: ₹768 கோடிTarget Revenue (FY27/28): ₹1,500 கோடி
📅 குறுகிய காலம்The stock may see minor activity around the August 22 meeting date as investors look for confirmation of shareholder approval.
📈 நீண்ட காலம்The merger is structurally significant as part of MPS's plan to scale its Research and Education solutions; successful integration of ADI BPO is critical for margin maintenance.
⚠ அபாய எச்சரிக்கைகள்
₹40.58 Cr in disputed tax demands for the transferor company
Integration risks associated with the aggressive M&A pipeline
👀 கவனிக்க வேண்டியவை
Monitor the voting results of the shareholder and creditor meetings on August 22, 2026, and subsequent NCLT final approval timelines for the merger execution.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
MPS Limited Consolidates US Subsidiaries; AJE-NC Merges into AJE-DE Effective Aug 1, 2026
MPS Limited has commenced a two-step internal restructuring to consolidate its US-based subsidiaries. In the first step, American Journal Experts (AJE-NC), which recorded FY26 revenue of ₹100.97 cr, merged into AJE-DE effective August 1, 2026. The final step will merge AJE-DE into MPS North America LLC (FY26 revenue: ₹114.49 cr), creating a single surviving entity. This consolidation involves entities representing approximately 28% of the group's TTM revenue, aimed at driving operational efficiency and reducing administrative overhead.
உச்சம் நம்பிக்கை
என்ன மாறியதுMPS Limited is consolidating its US subsidiaries, AJE-NC and AJE-DE, into MPS North America LLC through a two-step merger process.
ஏன் இது முக்கியம்This internal restructuring streamlines US operations, reduces compliance/administrative costs, and creates a more efficient platform for the company's Research Solutions business, which currently contributes 61.5% of total revenue.
AJE-NC Revenue (FY26): ₹100.97 கோடிMPS NA Revenue (FY26): ₹114.49 கோடிCombined Subsidiary Revenue vs TTM Group Revenue: ~28%Effective Date (Step 1): 01 ஆகஸ்ட் 2026
📅 குறுகிய காலம்The market is likely to view this as a routine but positive administrative cleanup that supports the company's broader efficiency goals.
📈 நீண்ட காலம்Supports the company's target of reaching ₹1,500 cr revenue by FY27/28 by creating a scalable and integrated US operational structure.
⚠ அபாய எச்சரிக்கைகள்
Integration risks of operational workflows across different US legal jurisdictions
👀 கவனிக்க வேண்டியவை
Watch for the completion announcement of the second merger step and monitor for potential margin expansion in the Research Solutions segment due to optimized administrative costs.
53% EBITDA Growth in Q1 FY27; MPS Ltd Reaffirms ₹300 Cr EBITDA Floor for FY27
MPS Limited reported its strongest Q1 performance to date, with revenue growing 20.4% YoY to ₹224.24 Cr and EBITDA surging 53% to ₹76.96 Cr. The company demonstrated significant operating leverage as EBITDA margins expanded to 34.3% from 27.0%, while headcount grew by less than 3%. Management reaffirmed its FY27 guidance to comfortably cross ₹300 Cr in EBITDA, supported by a shift toward AI-first knowledge solutions and outcome-based revenue models. Cash position remains healthy at ₹138.02 Cr against ₹37.63 Cr in borrowings.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has successfully transitioned from a service-heavy model to an AI-enabled knowledge solutions provider, allowing EBITDA to grow 2.6x faster than revenue in Q1.
ஏன் இது முக்கியம்The significant margin expansion and high operating leverage indicate that the company can scale revenue without a proportional increase in costs, structurally improving its profitability profile.
Q1 வருவாய்: ₹224.24 கோடிEBITDA Growth (YoY): 53.0%EBITDA லாப வரம்பு: 34.3%FY27 EBITDA Guidance: >₹300 CrQ1 வருவாய் vs TTM வருவாய்: 29.18%Cash and Equivalents: ₹138.02 கோடி
📅 குறுகிய காலம்The stock is likely to react positively to the record Q1 earnings and the management's high conviction in the ₹300 Cr EBITDA target.
📈 நீண்ட காலம்The company's strategy to reach ₹1,500 Cr revenue by FY27/28 through aggressive M&A and AI-driven organic growth suggests a significant scaling phase ahead.
⚠ அபாய எச்சரிக்கைகள்
Integration risks from the planned ₹600 Cr M&A pipeline
Potential volatility in the AJE (Author Solutions) segment during its strategic reset
👀 கவனிக்க வேண்டியவை
Monitor the execution of the M&A pipeline (25-35 active targets) and the scaling of the 'DigiCore' AI platform, which is driving the current margin expansion. Watch for the sustainability of the 34%+ EBITDA margin in the typically stronger second half of the fiscal year.
MPS Limited Schedules Aug 22 Meeting for Amalgamation of ADI BPO Services
MPS Limited has scheduled a Court-Convened Meeting of equity shareholders on August 22, 2026, to approve the amalgamation of ADI BPO Services Limited. This follows the NCLT Chennai Bench's order dated July 2, 2026. The company is actively dispatching notices and weblink letters to ensure shareholder participation via video conferencing. This merger is a key step in the company's stated strategy to reach a revenue target of Rs 1,500 Cr by FY27/28 through aggressive inorganic growth.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has moved from the NCLT 'First Motion' stage to the formal shareholder approval stage for the ADI BPO merger.
ஏன் இது முக்கியம்This represents a concrete execution of the company's M&A-led growth strategy. Successful integration is critical for achieving the ambitious FY27/28 revenue targets and utilizing the company's strong cash position.
Meeting Date: ஆகஸ்ட் 22, 2026E-voting Cut-off Date: ஆகஸ்ட் 17, 2026TTM வருவாய்: Rs 768 கோடிRevenue Target (FY27/28): Rs 1,500 கோடிNCLT Order Date: ஜூலை 2, 2026
📅 குறுகிய காலம்The stock may see interest leading up to the August 22 meeting as investors price in the progress of the inorganic growth strategy.
📈 நீண்ட காலம்The merger is structurally significant as it contributes to the company's goal of doubling revenue by FY28; long-term value depends on successful post-merger integration.
⚠ அபாய எச்சரிக்கைகள்
Integration risks of the acquired entity
Regulatory delays in final NCLT sanctioning
Potential for margin dilution if the acquired business has lower OPM than MPS's 30.1%
👀 கவனிக்க வேண்டியவை
Investors should monitor the voting results of the August 22 meeting and subsequent final NCLT approval. Educational focus should be on the financial contribution of ADI BPO to the consolidated entity once the merger is finalized.
MPS Limited reported a record Q1 FY27 with revenue growing 20.38% YoY to Rs 224.24 Cr and PAT increasing 42.99% to Rs 50.39 Cr. The company demonstrated significant operating leverage as EBITDA surged 53.03% YoY to Rs 76.96 Cr, driven by margin expansion to 34.32% from 27.00% a year ago. The Education segment saw a 42.21% revenue jump following the Unbound Medicine acquisition, while the total billed client base doubled to 841. Management reiterated its FY27 EBITDA guidance of over Rs 300 Cr, suggesting confidence in the growth trajectory for the remainder of the year.
உச்சம் நம்பிக்கை
என்ன மாறியதுMPS has transitioned into a 'Rule of 50' company (Growth + Margin > 50%) in Q1, with successful integration of Unbound Medicine and significant margin expansion in Corporate Learning.
ஏன் இது முக்கியம்The results validate the company's strategy of using M&A to drive high-margin, recurring revenue streams while maintaining a lean headcount (which grew only 2.7% despite 20% revenue growth).
📅 குறுகிய காலம்The stock is likely to react positively to the sharp EBITDA beat and the reiteration of strong full-year guidance.
📈 நீண்ட காலம்Structural growth is supported by an aggressive M&A pipeline and AI-enabled production workflows, aiming for a revenue scale-up to Rs 1,500 Cr by FY27/28.
⚠ அபாய எச்சரிக்கைகள்
Integration risks from the aggressive M&A pipeline (5 back-to-back deals planned)
Potential margin pressure if growth is chased reactively
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution of the M&A pipeline (25-35 targets) and the company's ability to maintain >34% EBITDA margins as it scales toward its Rs 1,500 Cr revenue target by FY28.
Rs 1 Cr Investment for Singapore Subsidiary and Q1 FY27 Results Approval
MPS Limited's board has approved the incorporation of a wholly-owned subsidiary in Singapore with an initial investment of up to Rs 1.00 crore. This move is intended to strengthen the company's international presence and facilitate its business objectives, with incorporation expected within 1-3 months. Additionally, the company has restructured its risk management by appointing General Counsel Mrs. Papinani Radha Rani as the Chief Risk Officer, effective July 21, 2026. The board also approved the un-audited financial results for Q1 FY27 and scheduled the 56th AGM for September 4, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுMPS is establishing a formal corporate presence in Singapore and has consolidated its legal and risk oversight under a single senior executive.
ஏன் இது முக்கியம்The Singapore subsidiary provides a strategic base for international expansion and M&A activities, which are critical for the company's goal to reach Rs 1,500 Cr in revenue by FY27/28. However, the initial investment is small (0.25% of net worth).
Investment in Singapore WOS: Rs 1.00 கோடிInvestment vs Net Worth: ~0.25%Investment vs TTM Revenue: ~0.13%AGM Date: செப்டம்பர் 4, 2026
📅 குறுகிய காலம்The market will likely react more to the specific Q1 FY27 earnings numbers than the administrative changes or the small Singapore investment.
📈 நீண்ட காலம்The Singapore entity supports the structural goal of international growth and M&A execution, though its immediate financial impact is negligible.
⚠ அபாய எச்சரிக்கைகள்
Integration risks from the aggressive M&A pipeline
Small initial capital for international expansion
👀 கவனிக்க வேண்டியவை
Investors should monitor the Q1 FY27 financial performance details (once fully published) and track how the Singapore subsidiary facilitates the company's aggressive M&A pipeline of 25-35 targets.
MPS Ltd to Invest ₹1 Cr in Singapore Subsidiary; Appoints New Chief Risk Officer
MPS Limited's board approved the Q1 FY27 financial results and the incorporation of a new Wholly Owned Subsidiary (WOS) in Singapore with an initial investment of up to ₹1 crore. The company also appointed Mrs. Papinani Radha Rani as the Chief Risk Officer, succeeding Mr. Vijendra Narendra Kumar, who remains the CTO. The 56th Annual General Meeting is scheduled for September 4, 2026. While the Singapore investment is small relative to the company's ₹3,499 crore market cap, it aligns with their stated strategy of international expansion.
உச்சம் நம்பிக்கை
என்ன மாறியதுMPS is establishing a direct corporate presence in Singapore and has restructured its risk management leadership by appointing a dedicated CRO.
ஏன் இது முக்கியம்The Singapore entity facilitates international business objectives, though the initial ₹1 crore investment is just 0.13% of TTM revenue. The management change ensures a focused approach to enterprise risk as the company pursues an aggressive M&A pipeline.
Singapore WOS Investment: ₹1,00,00,000Investment vs TTM Revenue: 0.13%Investment vs Net Worth: 0.25%AGM Date: 04 செப்டம்பர் 2026WOS Incorporation Timeline: 1-3 மாதங்கள்
📅 குறுகிய காலம்The stock may react to the specific Q1 FY27 earnings figures (revenue and margins) rather than the administrative changes or the small Singapore investment.
📈 நீண்ட காலம்The Singapore subsidiary is a structural step toward global expansion, but the company's long-term success depends on its ability to execute its ₹600 Cr M&A pipeline and reach its FY27/28 revenue goals.
⚠ அபாய எச்சரிக்கைகள்
Regulatory approvals for overseas investment
Integration risks of new international entities
👀 கவனிக்க வேண்டியவை
Investors should review the full Q1 FY27 financial results to assess progress toward the company's ₹1,500 Cr revenue target for FY27/28. Monitor the execution timeline for the Singapore subsidiary, expected to be completed within 1-3 months.
NCLT Issues First Motion Order for Amalgamation of ADI BPO Services with MPS Ltd
MPS Limited has received the NCLT's First Motion Order for the amalgamation of ADI BPO Services Limited into the company. ADI BPO reported a turnover of ₹61.88 Cr and a net worth of ₹133.79 Cr as of December 2025, which is significant compared to MPS's net worth of ₹398 Cr. The NCLT has dispensed with meetings for ADI BPO stakeholders but directed MPS to hold a meeting for its equity shareholders and unsecured creditors on August 22, 2026. This consolidation aligns with MPS's strategic goal to reach ₹1,500 Cr in revenue by FY27/28.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe legal process for merging ADI BPO Services into MPS Limited has advanced to the shareholder approval stage following the NCLT's First Motion Order.
ஏன் இது முக்கியம்This amalgamation simplifies the corporate structure and integrates BPO capabilities directly into MPS, supporting its long-term revenue growth targets and operational efficiency.
ADI BPO Net Worth: ₹133.79 கோடிADI BPO Turnover: ₹61.88 கோடிADI BPO Net Worth vs MPS Net Worth: 33.6%ADI BPO Turnover vs MPS TTM Revenue: 8.05%Shareholder Meeting Date: ஆகஸ்ட் 22, 2026
📅 குறுகிய காலம்The stock may see neutral to slightly positive sentiment as the merger clears a key regulatory milestone, with focus shifting to the August 22 meeting.
📈 நீண்ட காலம்Structurally positive as it consolidates group entities, potentially improving margins and supporting the company's target of ₹1,500 Cr revenue by FY28.
⚠ அபாய எச்சரிக்கைகள்
Integration risks of BPO operations
Potential administrative delays in final NCLT approval
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the shareholder and creditor meetings on August 22, 2026, and the subsequent final NCLT approval for the merger completion timeline.
NCLT Approves First Motion for Amalgamation of ADI BPO Services with MPS Ltd
MPS Limited has received the First Motion Order from NCLT Chennai for the merger of ADI BPO Services Limited into itself. ADI BPO reported a turnover of ₹61.88 Cr and a net worth of ₹133.79 Cr as of December 31, 2025, which is approximately 8% of MPS's TTM revenue. The NCLT has dispensed with meetings for the transferor company but directed a meeting of MPS equity shareholders on August 22, 2026. This move aligns with the company's stated strategy to reach ₹1,500 Cr in revenue through aggressive M&A.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe proposed merger of ADI BPO Services into MPS Limited has cleared the first major regulatory hurdle with the NCLT passing the First Motion Order.
ஏன் இது முக்கியம்This amalgamation is a step toward consolidating the group's BPO operations and contributes to the company's long-term revenue target of ₹1,500 Cr by FY27/28.
ADI BPO Turnover (Dec 2025): ₹61.88 கோடிADI BPO Net Worth: ₹133.79 கோடிTarget Turnover vs MPS TTM Revenue: ~8.06%Shareholder Meeting Date: 2026-08-22ADI BPO Current Assets: ₹115.32 கோடி
📅 குறுகிய காலம்The stock may see neutral to slightly positive sentiment as the merger process moves forward according to the regulatory timeline.
📈 நீண்ட காலம்The merger supports MPS's inorganic growth strategy and helps scale its BPO and Information Technology enabled services, though the immediate revenue impact is relatively small at ~8%.
⚠ அபாய எச்சரிக்கைகள்
Integration risks of the BPO entity
Regulatory approval for the final motion
Execution of the broader ₹600 Cr M&A pipeline
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the equity shareholder meeting scheduled for August 22, 2026, and the subsequent timeline for the final NCLT order to complete the amalgamation.
Chief People Officer Deepti Singh Resigns; Effective October 09, 2026
Ms. Deepti Singh has resigned from her position as Chief People Officer (CPO) and Senior Management Personnel at MPS Limited, effective October 09, 2026. The resignation was tendered on July 10, 2026, citing personal reasons, which allows for a nearly 90-day transition period. This leadership change comes as the company manages a global workforce of 3,071 employees and pursues an aggressive growth target to reach INR 1,500 Cr in revenue by FY27/28.
உச்சம் நம்பிக்கை
என்ன மாறியதுMs. Deepti Singh is stepping down from her role as Chief People Officer and Senior Management Personnel.
ஏன் இது முக்கியம்In a talent-dependent software and research solutions business with over 3,000 employees, the CPO role is vital for maintaining margins and integrating new acquisitions as part of the company's expansion strategy.
📅 குறுகிய காலம்Neutral; the long notice period suggests an orderly transition with no immediate impact on operations or financials.
📈 நீண்ட காலம்Limited; while the CPO is a senior role, the company has sufficient time to find a replacement to support its long-term growth targets.
👀 கவனிக்க வேண்டியவை
Monitor the company's announcement regarding a successor to ensure leadership continuity, particularly as the company executes its M&A-heavy growth strategy.
MPS Ltd Appoints Atul Vohra as Director; Former Solera Executive with $2.5B Scaling Experience
MPS Limited has appointed Mr. Atul Vohra as an Additional Director (Non-Executive Non-Independent) effective July 6, 2026. Mr. Vohra brings over 30 years of global leadership experience, including a tenure at Solera where he helped scale revenue six-fold to $2.5 billion. This appointment is strategically significant as MPS aims to double its revenue to Rs 1,500 Cr by FY27/28 through an aggressive M&A pipeline of 25-35 targets. Mr. Vohra's background in integrating approximately 50 acquisitions at Solera aligns directly with MPS's current growth trajectory.
உச்சம் நம்பிக்கை
என்ன மாறியதுAppointment of Mr. Atul Vohra as a Non-Executive Non-Independent Director, subject to shareholder approval.
ஏன் இது முக்கியம்The appointment adds significant global M&A and scaling expertise to the board, which is critical for MPS's stated strategy of aggressive inorganic growth to reach Rs 1,500 Cr in revenue.
📅 குறுகிய காலம்The appointment signals a commitment to the company's aggressive growth and M&A strategy, which may be viewed favorably by the market in the coming weeks.
📈 நீண்ட காலம்Structurally significant as it strengthens the board's ability to oversee international expansion and the integration of multiple back-to-back acquisitions planned for the next 2-3 years.
👀 கவனிக்க வேண்டியவை
Watch for the execution of the company's Rs 600 Cr M&A pipeline and how the new board expertise aids in the integration of upcoming acquisitions.
MPS Ltd Reports Record FY26 EPS of ₹102.11; Guides for ₹300 Cr+ EBITDA in FY27
MPS Limited reported a record FY26 EPS of ₹102.11, representing a 16.3% YoY growth, alongside a robust ROCE of 38.2%. Q4 FY26 revenue rose 12.66% YoY to ₹205.16 Cr, while EBITDA grew 20.53% to ₹67.51 Cr, showcasing strong operating leverage. The company successfully integrated Unbound Medicine, driving a 30.55% YoY revenue increase in the Education segment. Management has provided an aggressive FY27 EBITDA guidance of ₹300+ Cr, targeting a 21% 3-year CAGR.
முக்கிய அம்சங்கள்
Record FY26 EPS of ₹102.11, up 16.3% YoYFY27 EBITDA guidance set at ₹300+ Cr, implying significant growth from FY26's ₹236 CrQ4 FY26 EBITDA margins expanded to 32.9% from 30.76% YoYResearch segment continues to lead with a high 41.59% EBITDA marginCash and equivalents stood at ₹113.75 Cr against borrowings of ₹40.25 Cr
👀 கவனிக்க வேண்டியவை
The company's transition to an AI-first model and successful M&A strategy justify a positive outlook; monitor the execution of the ₹300 Cr EBITDA target for FY27.
MPS Ltd Re-appoints Statutory Auditors, Appoints KPMG for Internal Audit, Skips Final Dividend
MPS Limited has re-appointed Walker Chandiok & Co LLP as Statutory Auditors for a second five-year term and appointed KPMG as Internal Auditors for three years to align group-level governance. The company decided not to recommend a final dividend for FY 2025-26, citing the deployment of cash for the acquisition of Unbound Medicine, Inc., which closed in February 2026. The financial results for Q4 and FY26 received an unmodified audit opinion, indicating clean financial reporting. This capital allocation strategy reflects a focus on growth through acquisitions rather than immediate payouts.
முக்கிய அம்சங்கள்
Walker Chandiok & Co LLP re-appointed as Statutory Auditors for a 5-year term ending in 2031.KPMG appointed as Internal Auditors for the company and its material subsidiary for FY27-FY29.No final dividend recommended for FY26 to support growth and capital retention following recent M&A.Acquisition of Unbound Medicine, Inc. successfully completed on February 9, 2026.Auditors issued an unmodified opinion on both standalone and consolidated financial results for FY26.
👀 கவனிக்க வேண்டியவை
Investors should monitor the integration and performance of the Unbound Medicine acquisition as the company prioritizes growth over dividends. The appointment of a Big Four firm (KPMG) for internal audits is a positive sign for corporate governance.
MPS Limited has announced the resignation of its Chief Operating Officer (COO), Mr. Sreenivas Trichy Venkatraman, who is also designated as Senior Management Personnel. The resignation was tendered on May 05, 2026, citing personal reasons, and will become effective from the close of business hours on August 03, 2026. This provides the company with a three-month window to manage the leadership transition. Given the long notice period, immediate operational disruption is expected to be minimal.
முக்கிய அம்சங்கள்
Mr. Sreenivas Trichy Venkatraman resigned as Chief Operating Officer (COO) on May 05, 2026.The resignation is effective from August 03, 2026, allowing for a 90-day transition period.The departure is attributed to personal reasons and has been accepted by the company.The disclosure was made in compliance with Regulation 30 of SEBI Listing Regulations.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's announcements for the appointment of a successor to ensure leadership continuity. No immediate portfolio changes are necessary based on this planned management exit.
MPS Limited Receives Income Tax Demand Notice of INR 21.78 Crore for AY 2023-24
MPS Limited has received an Assessment Order and Demand Notice for the Assessment Year 2023-24, with a total tax demand amounting to INR 21.78 crore. The Income Tax Department enhanced the company's returned income by INR 4.82 crore, citing differences in interpretation regarding transfer pricing, depreciation, and withholding tax. The company believes the demand is inflated due to the application of an incorrect tax rate and the omission of a Foreign Tax Credit worth INR 1.15 crore. Management is currently in the process of filing an appeal and a rectification application, expecting no material impact on financial operations.
முக்கிய அம்சங்கள்
Total tax demand of INR 21.78 crore issued for Assessment Year 2023-24.Assessed income enhanced by INR 4.82 crore due to transfer pricing and liability treatment adjustments.Demand includes approximately INR 6.35 crore in interest charges under Section 234B.Company claims non-consideration of INR 1.15 crore in Foreign Tax Credits (FTC).Rectification application under Section 154 being filed to address incorrect tax rate application.
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the rectification application, as the company has identified specific calculation errors that could significantly lower the demand. The current impact is likely to be accounting-related rather than operational unless the appeal is rejected.
MPS Limited Appoints Deepti Singh as Chief People Officer to Drive Global Talent Strategy
MPS Limited has appointed Ms. Deepti Singh as Chief People Officer and Senior Management Personnel, effective March 23, 2026. With over 16 years of experience at high-growth firms like Flipkart and Incedo, her mandate is to align human capital with the company's goal of maintaining industry-leading EBITDA margins. She will specifically focus on integrating recent acquisitions like Unbound Medicine and scaling talent for the healthcare knowledge market. This strategic hire aims to instill a culture of surgical efficiency and high performance across the global organization.
முக்கிய அம்சங்கள்
Ms. Deepti Singh brings over 16 years of global HR leadership experience from companies including Flipkart, Incedo, and Target India.Mandate includes driving a high-performance culture to support the company's objective of maintaining top-tier EBITDA margins.Responsible for the people-side integration of recent and future acquisitions, such as Unbound Medicine.Strategic focus on value engineering in human capital to optimize operational costs and scale the global talent pool.Appointment is effective from the commencement of business hours on March 23, 2026.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step toward institutionalizing operational efficiency and managing the complexities of recent acquisitions. Monitor the company's ability to maintain its high margins as it scales its global workforce under new leadership.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
